Article Versions Notes

Jassin M, Onkelinx C, Bocuzzi V, E Silva B, Kwan O, Block A, Dubois S, Daulne C, Marcion G, Ormenese S, et al. Comparing a Novel Anti-BCMA NanoCAR with a Conventional ScFv-Based CAR for the Treatment of Multiple Myeloma. Cells. 2025; 14(24):1944. https://doi.org/10.3390/cells14241944

Jassin, Mégane, Chloé Onkelinx, Valentina Bocuzzi, Bianca E Silva, Oswin Kwan, Alix Block, Sophie Dubois, Coline Daulne, Guillaume Marcion, Sandra Ormenese, and et al. 2025. "Comparing a Novel Anti-BCMA NanoCAR with a Conventional ScFv-Based CAR for the Treatment of Multiple Myeloma" Cells 14, no. 24: 1944. https://doi.org/10.3390/cells14241944

Jassin, M., Onkelinx, C., Bocuzzi, V., E Silva, B., Kwan, O., Block, A., Dubois, S., Daulne, C., Marcion, G., Ormenese, S., Di Valentin, E., Baron, F., Grégoire, C., Ehx, G., Nguyen, T. T., & Caers, J. (2025). Comparing a Novel Anti-BCMA NanoCAR with a Conventional ScFv-Based CAR for the Treatment of Multiple Myeloma. Cells, 14(24), 1944. https://doi.org/10.3390/cells14241944